Steward Partners Investment Advisory, LLC

Position in SPRY — ARS Pharmaceuticals, Inc.

CIK 1723397 STAMFORD, CT

Position in SPRY

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$1,176,017

-$1,343,831 QoQ

Shares Held

146,453

-32.3% QoQ

Ownership

0.147%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Mar 31, 2026

Steward Partners Investment Advisory, LLC holds $46,353,299 across 170 Biotechnology names. SPRY ranks #7 (2.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VKTX	Viking Therapeutics, Inc.	338,246	$11,006,524
2	VRTX	Vertex Pharmaceuticals Inc / Ma	17,863	$7,976,544
3	ARGX	Argenx SE	9,371	$6,843,172
4	REGN	Regeneron Pharmaceuticals, Inc.	4,620	$3,569,596
5	BMRN	Biomarin Pharmaceutical Inc	35,027	$1,978,675
6	CRMD	CorMedix Inc.	229,465	$1,558,067
7	SPRY	ARS Pharmaceuticals, Inc. This page	146,453	$1,176,017
8	NKTR	Nektar Therapeutics	15,526	$1,117,095

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,176,017	146,453	-32.3%	Shares	Sole	2026-05-08
2025-12-31	$2,519,848	216,296	+47.4%	Shares	Sole	2026-02-12
2025-09-30	$1,474,254	146,692	+14.4%	Shares	Sole	2025-11-12
2025-06-30	$2,236,741	128,180	+164.4%	Shares	Sole	2025-08-12
2025-03-31	$609,878	48,480	+27.4%	Shares	Sole	2025-05-13
2024-12-31	$401,427	38,050	+47.2%	Shares	Sole	2025-02-06
2024-09-30	$374,825	25,850	+2054.2%	Shares	Sole	2024-11-14
2024-06-30	$10,212	1,200	-7.7%	Shares	Sole	2024-08-08
2024-03-31	$13,286	1,300	0.0%	Shares	Sole	2024-05-15
2023-12-31	$7,124	1,300	0.0%	Shares	Sole	2024-02-12
2023-09-30	$4,914	1,300	0.0%	Shares	Sole	2023-11-13
2023-06-30	$8,710	1,300	+8.3%	Shares	Sole	2023-08-14
2023-03-31	$7,812	1,200	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.